Physician profile
Michael Bishop
NPI 1548607278
$1,961.81
in general payments reported to CMS, 2019-2025
12 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $35.42 · 2021: $141 · 2022: $67.16 · 2023: $74.05 · 2024: $1,413 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,400 · Food and Beverage: $193 · Education: $13.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,400.00 |
| Food and Beverage | $192.67 |
| Education | $13.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adc Therapeutics America, INC. | $1,400.00 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $149.00 | 2023-2025 | Libtayo |
| Varian Medical Systems, INC. | $93.71 | 2019 | |
| Medtronic, INC. | $86.80 | 2021 | |
| Siemens Medical Solutions USA, INC. | $65.86 | 2022-2025 | Somatom Go.Top |
| Boston Scientific Corporation | $61.68 | 2020-2021 | |
| Accuray Incorporated | $25.37 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.76 | 2019 | |
| Incyte Corporation | $17.31 | 2023 | Jakafi, Monjuvi |
| Genzyme Corporation | $15.70 | 2021 | |
| Foundation Medicine, INC. | $15.37 | 2023 | Foundationone Liquid Cdx |
| Z-Medica, LLC | $12.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.